Research
Trial results posted for Bortezomib
Related compound: BortezomibView source →
Results posted for trial NCT02773030: A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma.